Cardiovascular drug-drug interactions
- PMID: 11407107
- DOI: 10.1016/s0733-8651(05)70209-5
Cardiovascular drug-drug interactions
Abstract
The drug-drug interactions discussed in this article have either documented or suspected clinical relevance for patients with cardiovascular disease and the clinician involved in the care of these patients. Oftentimes, drug-drug interactions are difficult, if not impossible, to predict because of the high degree of interpatient variability in drug disposition. Certain drug-drug interactions, however, may be avoided through knowledge and sound clinical judgment. Every clinician should maintain a working knowledge of reported drug-drug interactions and an understanding of basic pharmacokinetic and pharmacodynamic principles to help predict and minimize the incidence and severity of drug-drug interactions.
Similar articles
-
Cardiovascular drug therapy in the elderly.Cardiol Rev. 2007 Jul-Aug;15(4):195-215. doi: 10.1097/CRD.0b013e3180301b69. Cardiol Rev. 2007. PMID: 17575484 Review.
-
Cardiovascular agents.Semin Dial. 2010 Sep-Oct;23(5):480-2. doi: 10.1111/j.1525-139x.2010.00778.x. Semin Dial. 2010. PMID: 21069921 Review. No abstract available.
-
Implications of cytochrome P450 interactions when prescribing medication for hypertension.Arch Intern Med. 2002 Feb 25;162(4):405-12. doi: 10.1001/archinte.162.4.405. Arch Intern Med. 2002. PMID: 11863472 Review.
-
Interactions with cardiovascular drugs.Curr Probl Cardiol. 1993 Sep;18(9):531-81. doi: 10.1016/0146-2806(93)90004-l. Curr Probl Cardiol. 1993. PMID: 7900972 Review. No abstract available.
-
Cardiovascular therapeutics.Br J Hosp Med (Lond). 2008 Sep;69(9):M136-40. doi: 10.12968/hmed.2008.69.Sup9.31061. Br J Hosp Med (Lond). 2008. PMID: 18819300 No abstract available.
Cited by
-
Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.Drugs Aging. 2010 Sep 1;27(9):759-70. doi: 10.2165/11538460-000000000-00000. Drugs Aging. 2010. PMID: 20809665
-
Pharmacogenomics revolutionizing cardiovascular therapeutics: A narrative review.Health Sci Rep. 2024 Oct 20;7(10):e70139. doi: 10.1002/hsr2.70139. eCollection 2024 Oct. Health Sci Rep. 2024. PMID: 39435035 Free PMC article.
-
Endoplasmic Reticulum Stress Activates Unfolded Protein Response Signaling and Mediates Inflammation, Obesity, and Cardiac Dysfunction: Therapeutic and Molecular Approach.Front Pharmacol. 2019 Sep 10;10:977. doi: 10.3389/fphar.2019.00977. eCollection 2019. Front Pharmacol. 2019. PMID: 31551782 Free PMC article. Review.
-
Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.Ther Clin Risk Manag. 2005 Mar;1(1):3-13. doi: 10.2147/tcrm.1.1.3.53600. Ther Clin Risk Manag. 2005. PMID: 18360537 Free PMC article.
-
Potential Drug-Drug Interactions in a Cardiac Center: Development of Simple Software for Pattern Identification.J Tehran Heart Cent. 2022 Oct;17(4):215-222. doi: 10.18502/jthc.v17i4.11610. J Tehran Heart Cent. 2022. PMID: 37143746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources